PRECISION OPTICS CORPORATION, INC. Product Warranty Expense
PRECISION OPTICS CORPORATION, INC. (POCI) reported Product Warranty Expense of $0 for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProductWarrantyExpense · last filed 2022-09-27
- PRECISION OPTICS CORPORATION, INC. product warranty expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- PRECISION OPTICS CORPORATION, INC. product warranty expense for fiscal 2021 was $7.61K, a 41.18% decline from fiscal 2020.
- PRECISION OPTICS CORPORATION, INC. product warranty expense for fiscal 2020 was $12.94K, a 123.45% increase from fiscal 2019.
- PRECISION OPTICS CORPORATION, INC. product warranty expense for fiscal 2019 was $5.79K, a 5.21% decline from fiscal 2018.
| Period end | Product Warranty Expense 12 month |
|---|---|
| 2022-06-30 | $0.00 10-K · filed 2022-09-27 |
| 2021-06-30 | $7.61K 10-K · filed 2022-09-27 |
| 2020-06-30 | $12.94K 10-K · filed 2021-09-28 |
| 2019-06-30 | $5.79K 10-K · filed 2020-09-24 |
| 2018-06-30 | $6.11K 10-K · filed 2019-09-26 |
| 2017-06-30 | $14.84K 10-K · filed 2018-09-27 |
| 2016-06-30 | $4.19K 10-K · filed 2017-09-28 |
| 2015-06-30 | $32.48K 10-K · filed 2016-09-28 |
| 2014-06-30 | $11.92K 10-K · filed 2015-10-13 |
| 2013-06-30 | $2.01K 10-K · filed 2014-09-29 |
| 2012-06-30 | $1.32K 10-K · filed 2013-09-30 |
| 2011-06-30 | $2.66K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |